Published • loading... • Updated
ASX Slides on Oil Surge, CSL Cuts US Prices
The Melbourne-based biotech will discount medicines for Medicaid and invest $US1.5 billion to expand its Illinois plasma-therapies plant.
Summary by sharecafe.com.au
7 Articles
7 Articles
Sydney Morning Herald+3 Reposted by 3 other sources
CSL signs deal with Trump administration to slash prices for its medicines
Australia’s largest pharma company has agreed to lower the cost of its medicines in the US as it seeks to avoid the 100 per cent tariffs slapped on Australian-made pharmaceuticals.
·North Sydney, Australia
Read Full Article
ASX Slides on Oil Surge, CSL Cuts US Prices
The Australian share market experienced a downturn today as rising oil prices and climbing bond yields impacted investor sentiment. The S&P/ASX 200 index saw shares fall, with crude oil topping US$90 a barrel. Concurrently, Australian 10-year bond yields surged, reflecting broader global economic pressures. Tech stocks, in particular, faced declines during the session, though Austal
Coverage Details
Total News Sources7
Leaning Left3Leaning Right2Center1Last UpdatedBias Distribution50% Left
Bias Distribution
- 50% of the sources lean Left
50% Left
L 50%
C 17%
R 33%
Factuality
To view factuality data please Upgrade to Premium
